The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
Cardiology Research and Practice is a peer-reviewed, Open Access journal that publishes original research…
hindawi.com|By Hindawi Publishing Corporation
Canakinumab Yields Genetic and Disease Modifying Effects in TRAPS Patients
rheumnow.com
Ilaris Gets FDA Approval for Rare Febrile Disorders
The U.S. Food and Drug Administration has approved three new indications for canakinumab (Ilaris). The drug was previously approved for use in systemic JIA…
rheumnow.com